HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
USFDA completes inspection at Alembic Pharmaceuticals’ Oral Solid Formulation Facility
Jul-26-2024

United States Food and Drug Administration (USFDA) has completed GMP inspection at Alembic Pharmaceuticals’ Oral Solid Formulation Facility (F-I) located at Panelav. This was successfully completed without any Form 483 observation. The inspection was conducted from July 17, 2024 to July 26, 2024.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


  RELATED NEWS >>